Lead Acetate Trihydrate – Identification of Product
Chemical Code: CHE-L10
Chemical Name: Lead Acetate Trihydrate
Chemical Grade: AR
Chemical Formula: C₄H₆O₄Pb · 3H₂O
Chemical Weight: 379,33 g/mol
CAS No: 6080-56-4
Chemical Synonyms:
Lead Acetate Trihydrate – Hazards Identification
REACH No: No Data Available
Signal Word: Danger
Supplemental Hazard Information: Restricted to professional users.
Additional Hazard Information: This substance/mixture contains no components considered to be either persistent, bio accumulative and toxic (PBT), or very persistent and very bio accumulative (vPvB) at levels of 0.1% or higher.
Lead Acetate Trihydrate – Hazards statements
H360Df – May damage the unborn child. Suspected of damaging fertility.
H361f – Suspected of damaging fertility.
H373 – May cause damage to organs through prolonged or repeated exposure.
H400 – Very toxic to aquatic life.
H410 – Very toxic to aquatic life with long lasting effects.
Lead Acetate Trihydrate – Precautionary statements
P201 – Obtain special instructions before use.
P260 – Do not breathe dust/ fume/ gas/ mist/ vapours/ spray.
P280 – Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 – IF exposed or concerned: Get medical advice/ attention.
Lead Acetate Trihydrate – Composition of Chemical
Chemical Formula: C₄H₆O₄Pb · 3H₂O
EC No 1272/2008: No Data Available
Lead Acetate Trihydrate – First Aid Measures
General Advice: Consult a physician. Show this safety data sheet to the doctor in attendance.
If: Inhaled: If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
If: Skin Contact: Wash off with soap and plenty of water. Consult a physician.
If: Eye Contac: Flush eyes with water as a precaution.
If: Swallowed: Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Important Symptoms: The most important known symptoms and effects are described in the labeling section.
Immediate Medical Attention: No Data Available
Firefighting Measures
Extinguishing Media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Hazards Arising: No Data Available
Advice for Firefighters: Wear self-contained breathing apparatus for firefighting if necessary.
Info for Firefighting: No Data Available
Accidental Release Measures
Personal Precautions: Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental Precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.
Method for Containment: Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
Handling and Storage
Personal Precautions: Avoid formation of dust and aerosols. Avoid exposure – obtain special instructions before use. Provide appropriate exhaust ventilation at places where dust is formed.
Environmental Precautions: Keep container tightly closed in a dry and well-ventilated place. Store in cool place. Light sensitive. Air sensitive.
Exposure Controls | Personal Protection
Derived No Effect Level (DNEL)
Workers | Application Area | Exposure Routes | Health Effect | Value
No Data Available
Consumers | Application Area | Exposure Routes | Health Effect | Value
No Data Available
Predicted No Effect Concentration (PNEC)
No Data Available
Engineering Controls: Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Eye/Face Protection: Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin Protection: Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching gloves outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested: Dermatril® (KCL 740 / Size M)
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested: Dermatril® (KCL 740 / Size M)
data source: KCL GmbH, D-36124 test method: EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It should not be construed as offering an approval for any specific use scenario.
Body Protection: Impervious clothing, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory Protection: Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Physical and Chemical Properties
Appearance: Colourless crystals or White granules or powder
Odour: No Data Available
Odour Threshold: No Data Available
pH: No Data Available
Melting Point: Melting Point/Range: 75 °C – dec.
Boiling Point: No Data Available
Flash Point: No Data Available
Evaporation: No Data Available
Flammability: No Data Available
Upper/Lower Flammability or Explosive Limits: No Data Available
Vapour pressure: No Data Available
Vapour density: No Data Available
Relative density: 2,550 g/cm3
Water solubility: No Data Available
Partition Coefficien: No Data Available
Auto-ignition Temperature: No Data Available
Decomposition Temperature: No Data Available
Viscosity: No Data Available
Explosive properties: No Data Available
Oxidizing properties: No Data Available
Other Safety Info: No Data Available
Stability and Reactivity
Reactivity: No Data Available
Chemical Stability: Stable under recommended storage conditions.
Possibility of hazardous reactions: No Data Available
Conditions to Avoid: No Data Available
Incompatible Materials: Strong acids, Strong oxidizing agents.
Hazardous Decomposition Products: Hazardous decomposition products formed under fire conditions. – Carbon oxides, Lead oxides.
Other decomposition products – No Data Available
Toxicological Information
Acute Toxicity: LD50 Oral – Rat – 4.665 mg/kg
Skin Corrosion/Irritation: No Data Available
Serious Eye damage | Eye Irritation: No Data Available
Cell Mutagenicity: May alter genetic material.
Carcinogenicity: This is or contains a component that has been reported to be carcinogenic based on its IARC, OSHA, ACGIH, NTP, or EPA classification.
IARC: 2A – Group 2A: Probably carcinogenic to humans (Lead di(acetate) trihydrate).
Reproductive toxicity: Known human reproductive toxicant. May cause reproductive disorders.
Specific Target Organ Toxicity – Single Exposure: No Data Available
Specific Target Organ Toxicity – Repeated Exposure: No Data Available
Aspiration Hazard: No Data Available
Ecological Information
Ecological Toxicity: No Data Available
Ecological Persistence and degradability: No Data Available
Bio-accumulative Potential: No Data Available
Mobility in Soil: No Data Available
Results of PBT and vPvB Assessment: This substance/mixture contains no components considered to be either persistent, bio-accumulative and toxic (PBT), or very persistent and very bio-accumulative (vPvB) at levels of 0.1% or higher.
Other Adverse Effect: Very toxic to aquatic life.
Disposal Considerations
Waste Treatment Methods: Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Waste material must be disposed of in accordance with the Directive on waste 2008/98/EC as well as other national and local regulations. Leave chemicals in original containers. No mixing with other waste. Handle uncleaned containers like the product itself.
Contaminated packaging
Dispose of as unused product.
Transport Information
UN Number: ADR/RID: 1616
IMDG: 1616
IATA: 1616
UN Shipping Hazard: ADR/RID: LEAD ACETATE
IMDG: LEAD ACETATE
IATA: Lead acetate
Transport Hazard Class: ADR/RID: 6.1
IMDG: 6.1
IATA: 6.1
Packaging Group: ADR/RID: III
IMDG: III
IATA: III
Enviromental Hazards: ADR/RID: yes
IMDG Marine pollutant: yes
IATA: no
Special Precautions: No Data Available
Regulatory Information
Safety, Health and environmental regulations: This safety datasheet complies with the requirements of Regulation (EC) No.1907/2006.
Authorisations and/or restrictions on use REACH – Restrictions on the manufacture, placing on the market and use of certain dangerous substances, preparations and articles (Annex XVII) : Lead di(acetate) trihydrate.
Regulation (EC) No 649/2012 of the European. Parliament and the Council concerning the export and import of dangerous chemicals : Lead di(acetate) trihydrate.
REACH – Candidate List of Substances of Very High. Concern for Authorisation (Article 59). : Lead di(acetate) trihydrate.
Chemical Safety Assessment: For this product a chemical safety assessment was not carried out.
Additional Info: RTECS: OF8050000
Lead salts have been reported to cross the placenta and to induce embryo- and feto- mortality. They also have teratogenic effect in some animal species. No teratogenic effects have been reported with exposure to organometallic lead compounds. Adverse effects of lead on human reproduction, embryonic and fetal development, and postnatal (e.g., mental) development have been reported.
Excessive exposure can affect blood, nervous, and digestive systems. The synthesis of hemoglobin is inhibited and results in anemia. If left untreated, neuromuscular dysfunction, possible paralysis, and encephalopathy can result.
Additional symptoms of overexposure include: joint and muscle pain, weakness of the extensor muscles (frequently the hand and wrist), headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, blue line on the gums, insomnia, and metallic taste. High body levels produce increased cerebrospinal pressure, brain damage, and stupor leading to coma and often death., May cause convulsions.
Disclaimer
The information stated above is considered to be correct, but does not claim to be inclusive and shall only be used as a guideline. The information provided by this document is confirmed by our continuous updating of knowledge and adheres to the products appropriate safety precautions. It does not represent any guarantee of the product’s
properties. RLS Chemicals and its Associates shall not be held accountable for any damage’s consequent of handling the above product.
